| 臺大學術典藏 |
2021-01-27T03:23:40Z |
Seismic response of a mountain ridge prone to landsliding
|
Rault, C.;Chao, W.-A.;Gelis, C.;Burtin, A.;Chang, J.-M.;Marc, O.;Lai, T.-S.;Wu, Y.-M.;Hovius, N.;Meunier, P.; Rault, C.; Chao, W.-A.; Gelis, C.; Burtin, A.; Chang, J.-M.; Marc, O.; Lai, T.-S.; Wu, Y.-M.; Hovius, N.; Meunier, P.; YIH-MIN WU |
| 臺大學術典藏 |
2021-01-12T03:32:16Z |
Angiopoietin-2 Is Associated with Albuminuria and Microinflammation in Chronic Kidney Disease
|
Chang F.-C.; Lai T.-S.; Chiang C.-K.; Chen Y.-M.; Wu M.-S.; Chu T.-S.; Wu K.-D.; SHUEI-LIONG LIN |
| 臺大學術典藏 |
2021-01-12T03:32:11Z |
Multidisciplinary care program for advanced chronic kidney disease: Reduces renal replacement and medical costs
|
Lai T.S.; Chen P.M.; Chen P.Y.; Lai C.F.; Yang S.Y.; Wu V.; Chiang C.K.; Kao T.W.; Huang J.W.; Chiang W.C.; SHUEI-LIONG LIN; Hung K.Y.; Chen Y.M.; Chu T.S.; Wu M.S.; Wu K.D.; Tsai T.J. |
| 臺大學術典藏 |
2021-01-12T03:32:07Z |
Restricted Use of Erythropoiesis-Stimulating Agent is Safe and Associated with Deferred Dialysis Initiation in Stage 5 Chronic Kidney Disease
|
SHUEI-LIONG LIN; Chu T.-S.; Pan S.-Y.; Chiang W.-C.; Chen P.-M.; Liu H.-H.; Chou Y.-H.; Lai T.-S.; Lai C.-F.; Chiu Y.-L.; Lin W.-Y.; Chen Y.-M. |
| 臺大學術典藏 |
2021-01-12T03:32:06Z |
New-onset diabetes after acute kidney injury requiring dialysis
|
Yang S.-Y.; Huang T.-M.; SHUEI-LIONG LIN; Lin Y.-F.; Lai T.-S.; Chen L.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-01-12T03:32:05Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
SHUEI-LIONG LIN; Chen L.; Lin Y.-F.; Lin Y.-F.;Chen L.;Shuei-Liong Lin;Yeh Y.-C.;Huang T.-M.;Chou Y.-H.;Chang F.-C.;Chen Y.-T.;Yang S.-Y.;Lai T.-S.;Wu V.-C.;Chu T.-S.;Wu K.-D.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-01-12T03:32:01Z |
Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
|
SHUEI-LIONG LIN; Chen Y.-M.; Chu T.-S.; Tu Y.-K.; Lin Y.-C.;Lai T.-S.;Wu H.-Y.;Chou Y.-H.;Chiang W.-C.;Shuei-Liong Lin;Chen Y.-M.;Chu T.-S.;Tu Y.-K.; Lin Y.-C.; Lai T.-S.; Wu H.-Y.; Chou Y.-H.; Chiang W.-C. |
| 臺大學術典藏 |
2020-12-30T02:42:46Z |
Medical students' perceptions of their role as covert observers of hand hygiene
|
SHAN-CHWEN CHANG; Chen Y.-C.; Chie W.-C.; Tien K.-L.; Hung I.-C.; Pan S.-C.; Lai T.-S. |
| 臺大學術典藏 |
2020-12-24T08:38:24Z |
Multidisciplinary care program for advanced chronic kidney disease: Reduces renal replacement and medical costs
|
Chen P.M.;Lai T.S.;Chen P.Y.;Lai C.F.;Yang S.Y.;Wu V.;Chiang C.K.;Kao T.W.;Huang J.W.;Wen-Chih Chiang;Lin S.L.;Hung K.Y.;Chen Y.M.;Chu T.S.;Wu M.S.;Wu K.D.;Tsai T.J.; Chen P.M.; Lai T.S.; Chen P.Y.; Lai C.F.; Yang S.Y.; Wu V.; Chiang C.K.; Kao T.W.; Huang J.W.; WEN-CHIH CHIANG; Lin S.L.; Hung K.Y.; Chen Y.M.; Chu T.S.; Wu M.S.; Wu K.D.; Tsai T.J. |
| 臺大學術典藏 |
2020-12-24T08:38:23Z |
Reply to comment on "Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease"
|
Chen P.-M.; Lai T.-S.; Chen P.-Y.; WEN-CHIH CHIANG |
| 臺大學術典藏 |
2020-12-24T08:38:22Z |
Early initiation of immunosuppressive treatment in membranous nephropathy patients
|
Wu K.D.; Chu T.-S.; Chen Y.M.; WEN-CHIH CHIANG; Chiu Y.L.; Wu C.F.; Chou Y.H.; Chen P.M.; Lai T.S.; Chan C.K.;Lai T.S.;Chen P.M.;Chou Y.H.;Wu C.F.;Chiu Y.L.;Wen-Chih Chiang;Chen Y.M.;Chu T.-S.;Wu K.D.; Chan C.K. |
| 臺大學術典藏 |
2020-12-24T08:38:22Z |
Restricted Use of Erythropoiesis-Stimulating Agent is Safe and Associated with Deferred Dialysis Initiation in Stage 5 Chronic Kidney Disease
|
Chen P.-M.; WEN-CHIH CHIANG; Pan S.-Y.; Pan S.-Y.;Wen-Chih Chiang;Chen P.-M.;Liu H.-H.;Chou Y.-H.;Lai T.-S.;Lai C.-F.;Chiu Y.-L.;Lin W.-Y.;Chen Y.-M.;Chu T.-S.;Lin S.-L.; Liu H.-H.; Chou Y.-H.; Lai T.-S.; Lai C.-F.; Chiu Y.-L.; Lin W.-Y.; Chen Y.-M.; Chu T.-S.; Lin S.-L. |
| 臺大學術典藏 |
2020-12-24T08:38:22Z |
Pentoxifylline: Evidence strong enough for renoprotection?
|
Chen Y.-M.; WEN-CHIH CHIANG; Lai T.-S. |
| 臺大學術典藏 |
2020-12-24T08:38:20Z |
The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy
|
Lin W.C.; Chiu Y.L.; Fu T.Y.; Chou Y.H.; Wu C.F.; Lai T.S.; Chi J.N.; Chi J.N.;Lai T.S.;Wu C.F.;Fu T.Y.;Chou Y.H.;Chiu Y.L.;Lin W.C.;Wen-Chih Chiang;Chen Y.M.;Wu M.S.; WEN-CHIH CHIANG; Chen Y.M.; Wu M.S. |
| 臺大學術典藏 |
2020-12-24T08:11:57Z |
Primary biliary cirrhosis associated with minimal change disease [19]
|
Wu K.-D.; Tsai T.-J.; MING-SHIOU WU; Lin W.-C.; Lai T.-S.;Lin W.-C.;Ming-Shiou Wu;Tsai T.-J.;Wu K.-D.; Lai T.-S. |
| 臺大學術典藏 |
2020-12-24T08:11:50Z |
Angiopoietin-2 Is Associated with Albuminuria and Microinflammation in Chronic Kidney Disease
|
Chang F.-C.;Lai T.-S.;Chiang C.-K.;Chen Y.-M.;Ming-Shiou Wu;Chu T.-S.;Wu K.-D.;Lin S.-L.; Chang F.-C.; Lai T.-S.; Chiang C.-K.; Chen Y.-M.; MING-SHIOU WU; Chu T.-S.; Wu K.-D.; Lin S.-L. |
| 臺大學術典藏 |
2020-12-24T08:11:49Z |
Multidisciplinary care program for advanced chronic kidney disease: Reduces renal replacement and medical costs
|
Tsai T.J.; Wu K.D.; MING-SHIOU WU; Chu T.S.; Chen Y.M.; Hung K.Y.; Lin S.L.; Chiang W.C.; Huang J.W.; Kao T.W.; Chiang C.K.; Wu V.; Yang S.Y.; Chen P.M.; Lai T.S.; Chen P.Y.; Lai C.F. |
| 臺大學術典藏 |
2020-12-24T08:11:45Z |
The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy
|
MING-SHIOU WU; Chen Y.M.; Chiang W.C.; Chiu Y.L.; Lin W.C.; Chou Y.H.; Chi J.N.;Lai T.S.;Wu C.F.;Fu T.Y.;Chou Y.H.;Chiu Y.L.;Lin W.C.;Chiang W.C.;Chen Y.M.;Ming-Shiou Wu; Chi J.N.; Lai T.S.; Wu C.F.; Fu T.Y. |
| 臺大學術典藏 |
2020-12-24T07:43:56Z |
Primary biliary cirrhosis associated with minimal change disease [19]
|
Lai T.-S.; Lin W.-C.; Wu M.-S.; TUN-JUN TSAI; Wu K.-D. |
| 臺大學術典藏 |
2020-12-24T07:43:40Z |
Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease
|
TUN-JUN TSAI; Wu K.-D.; Chen Y.-M.; Chiang W.-C.; Wu V.; Lai C.-F.; Chen P.-Y.; Lai T.-S.; Chen P.-M. |
| 臺大學術典藏 |
2020-12-24T07:43:39Z |
Multidisciplinary care program for advanced chronic kidney disease: Reduces renal replacement and medical costs
|
Chen P.M.; Lai T.S.; Chen P.Y.; Lai C.F.; Yang S.Y.; Wu V.; Chiang C.K.; Kao T.W.; Huang J.W.; Chiang W.C.; Lin S.L.; Hung K.Y.; Chen Y.M.; Chu T.S.; Wu M.S.; Wu K.D.; TUN-JUN TSAI |
| 臺大學術典藏 |
2020-12-24T07:01:27Z |
Multidisciplinary care program for advanced chronic kidney disease: Reduces renal replacement and medical costs
|
JENQ-WEN HUANG; Kao T.W.; Chiang C.K.; Wu V.; Yang S.Y.; Chen P.Y.; Lai C.F.; Lai T.S.; Chen P.M.; Chiang W.C.; Lin S.L.; Hung K.Y.; Chen Y.M.; Chu T.S.; Wu M.S.; Wu K.D.; Tsai T.J. |
| 臺大學術典藏 |
2020-12-24T06:30:32Z |
Does Chinese herb nephropathy account for the high incidence of end-stage renal disease in Taiwan?
|
Wu K.-D.; Lin S.-L.; Wu M.-S.; Lee Y.-T.; Ho Y.-F.; Shen L.-J.; Lai T.-S.; YUNG-MING CHEN; Lin Wu F.-L. |
| 臺大學術典藏 |
2020-12-24T06:30:31Z |
Angiopoietin-2 Is Associated with Albuminuria and Microinflammation in Chronic Kidney Disease
|
Wu K.-D.; Lin S.-L.; Chu T.-S.; Wu M.-S.; YUNG-MING CHEN; Chiang C.-K.; Lai T.-S.; Chang F.-C. |
| 臺大學術典藏 |
2020-12-24T06:30:30Z |
Risk of developing severe sepsis after acute kidney injury: A population-based cohort study
|
Lai T.-S.; Wang C.-Y.; Pan S.-C.; Huang T.-M.; Lin M.-C.; Lai C.-F.; Wu C.-H.; Wu V.-C.; Chien K.-L.; Ko W.-J.; YUNG-MING CHEN; Shiao C.-C.; Yang W.-S.; Wang W.-J.; Chen L.; Wu P.-C.; Tsai P.-R.; Yeh Y.-C.; Hu F.-C.; Wu K.-D. |
